WEDNESDAY, Jan. 28, 2026 (HealthDay News) — Scientists may have uncovered a new cause of asthma that could change how the ...

In many patients, annual short-acting beta2-agonist prescription fulfillment is indicative of uncontrolled disease and increased incidence of exacerbations. Credit: Getty Images. Short-acting beta ...

Detroiters are hospitalized for asthma four times more often than Michigan residents overall. A proactive approach to care ...

The BATURA trial ended early due to high efficacy data at pre-planned analysis. Topline results were announced from a phase 3b trial evaluating albuterol/budesonide metered dose inhaler in patients ...

DENVER — National Jewish Health researchers are looking for ways to identify patients with untreated mild persistent asthma who might benefit from daily inhaled treatment based on inflammatory ...

Please provide your email address to receive an email when new articles are posted on . The treatment group had reductions in FeNO 1 week after a single dose. Reductions were significant compared with ...

Earlier this month, Apogee Therapeutics reported positive interim Phase 1b data for zumilokibart (APG777) in mild-to-moderate asthma, showing a favorable safety profile and durable suppression of Type ...

Please provide your email address to receive an email when new articles are posted on . LOUISVILLE, Ky. — Patients with asthma had a greater risk for ischemic heart disease compared with those without ...

APG808 was well-tolerated and there were no severe adverse events. Credit: Explode via Shutterstock. At the 2025 European Respiratory Society (ERS) International Congress takig place in Amsterdam, the ...

Providers from an asthma primary care program found telemedicine to be effective in both caring for children with asthma and addressing unmet social needs that may exacerbate their asthma outcomes.

In a recent study published in the Respiratory Research journal, researchers in Hong Kong assessed the deterioration of asthma control in patients recovering from mild to moderate coronavirus disease ...

Asthma may not be driven by the molecules scientists have blamed for decades. Researchers have identified “pseudo leukotrienes,” inflammation-triggering compounds formed by uncontrolled free-radical ...